NICE (@NICEComms) / X

NICE

17.3K posts

NICE

@NICEComms

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

London and Manchester, UK

Joined October 2009

NICE
@NICEComms
10h
We want to hear your views on a proposed update to our guideline that recommends clinicians consider the use of procalcitonin testing for some people with suspected severe sepsis. The consultation closes on July 10. Find out how to take part: nice.org.uk/guidance/indev…
897
NICE
@NICEComms
13h
Thousands of people with an autoimmune condition that leads to extensive hair loss are set to benefit after we recommended a new daily pill treatment today. Find out more about deuruxolitinib: nice.org.uk/guidance/indev…
1.4K
NICE
@NICEComms
Jun 25
Getting the right healthtech to patients faster matters. Our chief executive spoke to the Science and Technology Select Committee yesterday on our work to establish a structured pathway from evidence to adoption. 👉Developing or adopting healthtech nice.org.uk/what-nice-does…
1.2K
NICE
@NICEComms
Jun 25
"NICE's healthtech guidance provided me with the perfect catalyst for change." With 187 slide sheet products on the market, how do you choose? Evelyn Otunbade shares how our guidance helped balance quality and cost. Read Evelyn's story: nice.org.uk/news/blogs/fro… @NHSSupplyChain
1.2K
NICE
@NICEComms
Jun 25
NICE has recommended a new first-line NHS treatment for locally advanced cervical cancer. Pembrolizumab with chemoradiotherapy has the potential to improve survival and increase the chance of cure for people: nice.org.uk/guidance/await…
1.6K
NICE reposted
Breakthrough T1D UK
@BT1DUK
Jun 23
"The greatest gift teplizumab has given us is time. As a mother, every month and every year that Dima can continue being a child without insulin injections, carb counting and the daily burden of T1D feels incredibly precious." Elena's son Dima was nine when he received a
1.9K
NICE
@NICEComms
Jun 24
We've published final guidance recommending seladelpar for people living with primary biliary cholangitis, a rare liver disease where the immune system attacks the bile ducts, which can lead to liver failure. Around 3,700 people could benefit: nice.org.uk/guidance/ta117…
00:00
1.7K
NICE reposted
NICE
@NICEComms
Jun 23
Elena signed her 9-year-old son Dima up to a screening study and found out he had early-stage type 1 diabetes. He received teplizumab, a new treatment now recommended for NHS use that can delay onset by nearly 3 years. Read more: nice.org.uk/news/articles/…
1.7K
NICE
@NICEComms
Jun 23
NICE has recommended cemiplimab for adults with recurrent or metastatic cervical cancer after platinum-based chemotherapy: nice.org.uk/guidance/indev…
1.6K
NICE
@NICEComms
Jun 23
Elena signed her 9-year-old son Dima up to a screening study and found out he had early-stage type 1 diabetes. He received teplizumab, a new treatment now recommended for NHS use that can delay onset by nearly 3 years. Read more: nice.org.uk/news/articles/…
1.7K
NICE
@NICEComms
Jun 23
NICE has recommended teplizumab for NHS use, a first-of-its-kind treatment that can delay the onset of type 1 diabetes by an average of nearly three years. England is the first country in Europe to approve it through a health technology appraisal: nice.org.uk/news/articles/…
3.1K
NICE
@NICEComms
Jun 23
Replying to @NICEComms
Karen Addington MBE, Chief Executive of @BT1DUK shares what this moment means for the type 1 community. Teplizumab will be available to NHS patients in England within 90 days of final guidance publication, with around 1,100 people expected to be eligible in the first year.
753
NICE
@NICEComms
Jun 23
Dr Elizabeth Robertson, Director of Research and Clinical at @DiabetesUK reflects on what this landmark recommendation means for the future of type 1 diabetes treatment⬇️
372
NICE
@NICEComms
Jun 19
Just over 1,100 people with an aggressive form of lung cancer could be set to benefit after we recently recommended a new medicine in final guidance. Find out more about serplulimab: nice.org.uk/guidance/indev…
1.5K
NICE
@NICEComms
Jun 19
Thousands of people with a chronic condition that causes excessive, uncontrollable underarm sweating could benefit after we recommended a new treatment today. Find out more about glycopyrronium bromide cream: nice.org.uk/guidance/indev…
1.3K